Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.
Madrigal Pharmaceuticals stock last closed at $150.94, down 1.57% from the previous day, and has increased 139.51% in one year. It has overperformed other stocks in the Biotechnology industry by 1.7 percentage points. Madrigal Pharmaceuticals stock is currently +163.83% from its 52-week low of $57.21, and -53.22% from its 52-week high of $322.67.
As of Sep 25, 2023, there are 18.47M MDGL shares outstanding. The market value of MDGL is $2.79B. In the last 24 hours, 252,751 MDGL shares were traded.
How to Buy Madrigal Pharmaceuticals Stock
Not sure how to invest in Madrigal Pharmaceuticals stock? Here's how.
Choose where to buy Madrigal Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Madrigal Pharmaceuticals stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your brokerage account: Pick your payment method and add your details.
Research Madrigal Pharmaceuticals stock: The Madrigal Pharmaceuticals ticker symbol is MDGL. Is Madrigal Pharmaceuticals stock a good investment? Should you buy shares of MDGL? How do MDGL's underlying business fundamentals look? Do top analysts think Madrigal Pharmaceuticals is a good buy? Why has MDGL's stock price moved recently? (Hint: Our stock analysis website can help you decide if MDGL is a good stock to buy).
Make your MDGL purchase: Decide if you will purchase MDGL shares at the current market price or use a limit order to buy MDGL stock at a given price.
Get key alerts regarding your MDGL investment: Create a watchlist to get live updates on your position in Madrigal Pharmaceuticals stock.
Step 1: Choose where to buy Madrigal Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy MDGL shares.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Tech to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in MDGL stock today.
Once you have chosen the best place to buy Madrigal Pharmaceuticals stock, it's crucial to research their stock prior to buying, so you truly understand the risk as well as the opportunity.
Madrigal Pharmaceuticals quick stats
MDGL Price
$150.94
1w %
-7.73%
1y %
139.51%
5y %
-32.08%
P/E
-8.09x
P/B
26.94x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$329.80M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$2.79B
Next Earnings
Nov 1, 2023
Next Dividend
N/A
Madrigal Pharmaceuticals Overview
WallStreetZen was designed to help average investors do more accurate fundamental analysis quickly.
There are more short-term assets than short-term liabilities on the MDGL balance sheet.
MDGL has cash burn of 277127000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the MDGL balance sheet.
Signs that MDGL is not financially healthy:
MDGL has $298.42M in cash and short term investments. This is not enough to cover its annual cash burn of $277.13M.
Total MDGL debt is higher than 5 years ago, relative to shareholder equity.
MDGL has a relatively high debt to equity ratio of 1.92.
Do Wall Street analysts think it's a good time to buy Madrigal Pharmaceuticals stock
Out of 5 Wall Street analysts who track MDGL, the consensus analyst rating on MDGL is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent MDGL Analyst Recommendations
Liisa Bayko, a top 9% analyst from Evercore ISI Group maintains MDGL with a buy rating and maintains their MDGL price target from $325.00 to $325.00, on Sep 19, 2023.
Ed Arce, a bottom 2% analyst from HC Wainwright & Co. reiterates MDGL with a buy rating and maintains their MDGL price target from $225.00 to $225.00, on Sep 14, 2023.
Mayank Mamtani, a top 4% analyst from B. Riley Securities reiterates MDGL with a hold rating and maintains their MDGL price target from $224.00 to $224.00, on Sep 11, 2023.
Jay Olson, a top 5% analyst from Oppenheimer maintains MDGL with a buy rating and lowers their MDGL price target from $350.00 to $285.00, on Aug 9, 2023.
Edward Nash, a bottom 18% analyst from Canaccord Genuity reiterates MDGL with a strong buy rating and maintains their MDGL price target from $336.00 to $336.00, on Jul 18, 2023.
In the last 12 months, insiders at MDGL have bought as many shares as they have sold.
Robert E. Waltermire, Senior VP Chief Pharma Dev. of MDGL, was the latest MDGL insider to sell. They sold $27,619.00 worth of MDGL stock on Mar 1, 2023.
No, Madrigal Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your MDGL purchase
You have two main order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally fine for most investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.
Click the Open button and your broker will place the order.
If you need more assistance investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Madrigal Pharmaceuticals share?
As of Sep 25, 2023, it costs $150.94 to buy one share of Madrigal Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.663 shares of MDGL.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.